WallStSmart
LFCR

Lifecore Biomedical Inc.

NASDAQ: LFCR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$5.07
+2.63% today

Updated 2026-04-30

Market cap
$190.38M
P/E ratio
P/S ratio
1.47x
EPS (TTM)
$-1.27
Dividend yield
52W range
$4 – $9
Volume
0.4M

Lifecore Biomedical Inc. (LFCR) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$10.87M$-2.06M$17.52M$9.44M$7.48M$14.47M$22.18M$21.23M$21.05M$26.16M$21.78M$29.33M$19.78M$16.02M$-17.04M$16.47M$-24.40M$-22.59M$257000.00$-206000.00
Capital expenditures$4.75M$6.78M$4.24M$4.58M$44.87M$6.68M$5.37M$8.88M$14.89M$17.51M$40.87M$22.59M$33.59M$44.73M$26.69M$25.22M$28.13M$29.94M$18.39M$13.41M
Depreciation
Stock-based comp$-323000.00$933000.00$1.02M$1.95M$1.87M$1.70M$1.36M$1.58M$3.46M$3.96M$4.40M$3.56M$2375.00$3.36M$2.61M$2.61M$6.20M$10.16M
Free cash flow$6.12M$-8.84M$13.28M$4.86M$-37.39M$7.79M$16.81M$12.35M$6.16M$8.64M$-19.08M$6.74M$-13.81M$-28.71M$-43.73M$-8.75M$-52.53M$-52.53M$-18.14M$-13.62M
Investing cash flow
Financing cash flow
Dividends paid$44.58M$700000.00$212000.00$274000.00$3.08M
Share repurchases
Debt repayment
Net change in cash